Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.

Rashna Madan1, Robert Gormley, Alina Dulau

  • 1Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10467, USA.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|January 31, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges of chimerism analysis using Next-Generation sequencing in a patient with complex chromosomal alterations.

Human immunology·2026
Same author

Artificial Intelligence in Oncology: Clinical Applications, Challenges, and Opportunities.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Emerging concept of precise neuromodulation: Genetics-based neuromodulation in spinal cord injury.

Neural regeneration research·2026
Same author

Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms.

Neural regeneration research·2026
Same author

Immuno-PET/CT Imaging of Trop2 Expression with [<sup>18</sup>F]AlF-RESCA-RT4 Enhances Diagnosis of Breast Cancers and the Metastases.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

[18F]RCCB6 PET/CT in Diagnosing Clear Cell Renal Cell Carcinomas: A Prospective Comparison Study with [18F]FDG PET/CT and Conventional Imaging.

Cancer discovery·2026

The immunophenotype of diffuse large B-cell lymphomas (DLBCL) differs between acquired immunodeficiency syndrome (AIDS) and non-AIDS patients. AIDS-associated DLBCL exhibits an intermediate germinal center/activated B-cell phenotype, unlike non-AIDS DLBCL.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Diffuse large B-cell lymphomas (DLBCL) in immunocompetent patients are classified into germinal center (GC) and activated B-cell (ABC) types based on gene expression.
  • The immunophenotype of DLBCL in acquired immunodeficiency syndrome (AIDS) patients remains poorly understood.
  • Understanding DLBCL subtypes is crucial for targeted therapies and improved patient outcomes.

Purpose of the Study:

  • To investigate differences in protein expression of GC and ABC markers between AIDS-associated and non-AIDS DLBCL.
  • To determine if patient immune status (AIDS vs. non-AIDS) correlates with DLBCL immunophenotype.
  • To characterize the immunophenotypic profile of DLBCL in the context of HIV infection.

Main Methods:

  • Immunohistochemical staining of tissue microarrays from 39 de novo DLBCL cases (12 AIDS-associated, 27 non-AIDS).

Related Experiment Videos

  • Evaluation of GC markers (BCL6, CD10, CyclinH) and ABC markers (MUM1, CD138, PAK1, CD44, BCL2).
  • Quantitative scoring of marker expression and generation of 2D contour-frequency plots to visualize immunophenotypes.

    • Main Results:

    • Non-AIDS DLBCL cases segregated into two distinct clusters: one with a high GC phenotype and another with a high ABC phenotype.
    • AIDS-associated DLBCL cases formed a single aggregate, distinct from the non-AIDS clusters (P=0.02).
    • AIDS-related DLBCL exhibited an intermediate GC/ABC immunophenotype when compared to non-AIDS DLBCL subtypes.

    Conclusions:

    • Confirms the existence of distinct GC and ABC subtypes in non-AIDS DLBCL.
    • Demonstrates that AIDS status is a significant predictor of DLBCL immunophenotype.
    • Highlights the potential for distinct biological mechanisms and therapeutic strategies for AIDS-associated DLBCL.